The stock hit a high price of Rs 642.6 and low of Rs 621.0 during the session.
The return on equity (ROE) for the stock stood at 24.32 per cent. Traded volume on the counter stood at 12:24PM shares and turnover at Rs 3.53 crore around that time.
The stock of Aurobindo Pharma Ltd. quoted a 52-week high and 52-week low prices of Rs 1063.75 and Rs 621.0, respectively.
The Beta value of the counter, which measures its volatility in relation to the broader market, stood at 1.06.
Promotor/FII Holding
Promoters held 51.83 per cent stake in the company as of 30-Sep-2021, while overseas investors held 23.41 per cent and domestic institutional investors had 13.82 per cent.
Key Financials
The company reported consolidated sales of Rs 6038.5 crore for the quarter ended 30-Sep-2021, up 4.41 per cent from previous quarter’s Rs 5783.29 crore and up 7.63 per cent from the year-ago quarter’s Rs 6537.19 crore.
Net profit after tax for the latest quarter stood at Rs 696.99 crore, down 13.55 per cent from the same quarter a year ago.
